Gene · 5590
Papers4,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the regulatory role of lncRNA in cancer immunity. | Front Oncol | 2023 | 37637063 | PubTator, text mining | PubMed |
| Molecular mechanism of palmitic acid and its derivatives in tumor progression. | Front Oncol | 2023 | 37637038 | PubTator, text mining | PubMed |
| Circulating Sphingolipids and Glucose Homeostasis: An Update. | Int J Mol Sci | 2023 | 37628901 | PubTator, text mining | PubMed |
| Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response. | Biology (Basel) | 2023 | 37626933 | PubTator, text mining | PubMed |
| Tripartite Motif-Containing Protein 32 (TRIM32): What Does It Do for Skeletal Muscle? | Cells | 2023 | 37626915 | PubTator, text mining | PubMed |
| eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation. | J Biol Chem | 2023 | 37611825 | PubTator, text mining | PubMed |
| Distinction between rhinitis alone and rhinitis with asthma using interactomics. | Sci Rep | 2023 | 37573373 | PubTator, text mining | PubMed |
| Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades. | J Biol Chem | 2023 | 37572851 | PubTator, text mining | PubMed |
| The Key Role of Mitochondria in Somatic Stem Cell Differentiation: From Mitochondrial Asymmetric Apportioning to Cell Fate. | Int J Mol Sci | 2023 | 37569553 | PubTator, text mining | PubMed |
| Bioinformatic platforms for clinical stratification of natural history of atherosclerotic cardiovascular diseases. | Eur Heart J Cardiovasc Pharmacother | 2023 | 37562936 | PubTator, text mining | PubMed |
| Application of G-quadruplex targets in gastrointestinal cancers: Advancements, challenges and prospects. | World J Gastrointest Oncol | 2023 | 37546556 | PubTator, text mining | PubMed |
| The Effect of Training Type on The Signaling P athway of Ceramide-Dependent Insulin Resistance in The Flexor Hallucis Longus Muscle of Streptozotocin-Induced Diabetic Rats. | Cell J | 2023 | 37543859 | PubTator, text mining | PubMed |
| Effects of astaxanthin on depressive and sleep symptoms: A narrative mini-review. | Heliyon | 2023 | 37539097 | PubTator, text mining | PubMed |
| EpiMix is an integrative tool for epigenomic subtyping using DNA methylation. | Cell Rep Methods | 2023 | 37533639 | PubTator, text mining | PubMed |
| Investigating pathogenic SNP of PKCι in HCV-induced hepatocellular carcinoma. | Sci Rep | 2023 | 37532886 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma. | Clin Cancer Res | 2023 | 37527025 | PubTator, text mining | PubMed |
| Editorial of Special Issue "Molecular Mechanisms of Allergy and Asthma 2.0". | Int J Mol Sci | 2023 | 37511070 | PubTator, text mining | PubMed |
| Alternative Splicing, RNA Editing, and the Current Limits of Next Generation Sequencing. | Genes (Basel) | 2023 | 37510291 | PubTator, text mining | PubMed |
| Alzheimer's Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative Stress. | Antioxidants (Basel) | 2023 | 37507998 | PubTator, text mining | PubMed |
Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency followed by cisplatin and nab paclitaxel. | Biomark Res | 2023 | 37491309 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5590/papers?page=9